Guizhou Sanli Pharmaceutical Co.,Ltd. (603439.SH) plans to acquire a 40% stake in its subsidiary, Sankang Partnership.
Guizhou Sanli (603439.SH) issued an announcement that the company intends to acquire Guizhou Healthy Traditional Chinese Medicine and Food Ingredients Industry Development Group...
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that it intends to acquire 40% of the equity of its controlling subsidiary Guizhou Sankang Enterprise Management Partnership Enterprise (Limited Partnership), held by Guizhou Health Agricultural Traditional Chinese Medicine Ingredients Industry Development Group Co., Ltd. (referred to as "Health Farm") for a transfer price of 40 million RMB, to be paid in cash.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


